A-Alpha Bio
The protein-protein interaction company.
- Headquarters
- Seattle, Washington
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- aalphabio.com
- Total Funding
- $46.0M
- Last Round
- $22.4M Series AJul 2023
About
A-Alpha Bio is a Seattle-based biotechnology company using its AlphaSeq and AlphaBind platforms to generate and analyze billions of protein-protein interaction data points. By combining high-throughput synthetic biology experiments with machine learning, A-Alpha Bio accelerates antibody discovery, targeted protein degradation, and the development of high-impact medicines for cancer, infectious disease, and more.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account